SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017320
Filing Date
2024-05-16
Accepted
2024-05-16 17:01:14
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cont20240331_10q.htm   iXBRL 10-Q 1471702
2 EXHIBIT 31.1 ex_651405.htm EX-31.1 15880
3 EXHIBIT 31.2 ex_651406.htm EX-31.2 12659
4 EXHIBIT 32.1 ex_651407.htm EX-32.1 9054
5 EXHIBIT 32.2 ex_651408.htm EX-32.2 6049
11 g01.jpg GRAPHIC 85966
  Complete submission text file 0001437749-24-017320.txt   5791704

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctnm-20240331.xsd EX-101.SCH 37402
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctnm-20240331_cal.xml EX-101.CAL 29583
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctnm-20240331_def.xml EX-101.DEF 301289
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctnm-20240331_lab.xml EX-101.LAB 260283
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctnm-20240331_pre.xml EX-101.PRE 321823
61 EXTRACTED XBRL INSTANCE DOCUMENT cont20240331_10q_htm.xml XML 814307
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42001 | Film No.: 24956531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)